Substituted benzylamino-6-(trifluoromethyl)pyrimidin-4(1H)-ones: a novel class of selective human A-FABP inhibitors.
Ringom, R., Axen, E., Uppenberg, J., Lundback, T., Rondahl, L., Barf, T.(2004) Bioorg Med Chem Lett 14: 4449-4452
- PubMed: 15357970 
- DOI: https://doi.org/10.1016/j.bmcl.2004.06.058
- Primary Citation of Related Structures:  
1TOU - PubMed Abstract: 
The synthesis and biological evaluation of novel human A-FABP inhibitors based on the 6-(trifluoromethyl)pyrimidine-4(1H)-one scaffold is described. Two series of compounds, bearing either an amino or carbon substituent in the 2-position of the pyrimidine ring were investigated. Modification of substituents and chain length optimization led to novel compounds with low micromolar activity and good selectivity for human A-FABP.
Organizational Affiliation: 
Department of Medicinal Chemistry, Biovitrum AB, SE-751 37 Uppsala, Sweden.